Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.58 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL28151318 | 0.86 | TSHR (0.44) | TSHRACHEHSD17B10HCAR2HTT | |
| SCHEMBL5252228 | 0.84 | CYP19A1 (0.55) | TSHRALDH1A1CYP3A4CYP19A1LMNA | |
| SCHEMBL2074168 | 0.80 | TSHR (0.50) | TSHRACHEHSD17B10ALDH1A1TDP1 | |
| Ethylene SCHEMBL28777120 | 0.79 | CYP19A1 (0.50) | TSHRALDH1A1CYP3A4CYP19A1LMNA | |
| SCHEMBL17873457 | 0.74 | HCAR2 (0.41) | TSHRALDH1A1TDP1HCAR2CYP19A1 | |
| SCHEMBL3607175 | 0.74 | LMNA (0.42) | TSHRALDH1A1CYP19A1LMNAHTT | |
| SCHEMBL826834 | 0.74 | ALDH1A1 (0.50) | TSHRHSD17B10ALDH1A1TDP1HCAR2 | |
| SCHEMBL2167915 | 0.74 | ALDH1A1 (0.50) | TSHRHSD17B10ALDH1A1TDP1CYP19A1 | |
| SCHEMBL529746 | 0.74 | MAPT (0.50) | TSHRALDH1A1HCAR2CYP3A4CYP19A1 | |
| SCHEMBL7666882 | 0.74 | CYP19A1 (0.39) | TSHRALDH1A1CYP3A4CYP19A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119486728-A | Proteolysis targeting chimeric of mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 特吉德治疗公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| WO-2022073425-A1 | SMALL MOLECULE COMPOUND SERVING AS JAK KINASE INHIBITOR, AND USE THEREOF | 嘉兴特科罗生物科技有限公司 | 2022-04-14 | — | — | WO | disclosed |
| EP-2952096-B1 | Amide compound, an arthropod pest control agent and a method for controlling arthropod pest | SUMITOMO CHEMICAL CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-9814235-B2 | Method for controlling arthropod pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-14 | — | — | US | disclosed |
| CN-103396359-B | Iminipyridine derivatives and they purposes as microbicide | 先正达参股股份有限公司 | 2016-06-29 | — | — | CN | disclosed |
| WO-2016049586-A2 | NON-BETA LACTAM ANTIBIOTICS | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2016-03-31 | — | — | WO | disclosed |
| EP-2049488-B1 | N'-CYANO-N-ALKYL HALIDE IMIDE AMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952096-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-03 | — | — | US | disclosed |
| CN-101460502-A | Bicyclic enamino(thio)carbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2009-06-17 | — | — | CN | disclosed |
| CN-101454316-A | Substituted enaminocarbonyl compounds for use as pesticides | BAYER CROPSCIENCE AG (DE) | 2009-06-10 | — | — | CN | disclosed |
| US-7528140-B2 | Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors | TEIJIN LIMITED (JP) | 2009-05-05 | — | — | US | disclosed |
| US-7528140-B2 | Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors | TEIJIN LIMITED (JP) | 2009-05-05 | — | — | US | disclosed |
| CN-101415682-A | Substituted enaminocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2009-04-22 | — | — | CN | disclosed |
| WO-2002090328-A1 | THE PREPARATION OF SUBSTITUTED PYRIDINES UTILIZING NITRIC AND AN ANHYDRIDE | REILLY INDUSTRIES, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| US-6476021-B1 | Compounds having cGMP-PDE inhibitory effect | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| CN-1090189-C | pyrazolopyrimidines | JANSSEN PHARMACEUTICA NV (BE) | 2002-09-04 | — | — | CN | disclosed |
| EP-1048666-A1 | NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | EP | disclosed |
| CN-1205009-A | Pyrazolopyrimidines type compound | JANSSEN PHARMACEUTICA NV (BE) | 1999-01-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | H1-0, H1-3, H1-2 | TSHR 507/4885ACHE 710/4885HSD17B10 1036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.